Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.170
-0.095 (-7.51%)
Jul 24, 2026, 5:13 PM CET
Pila Pharma AB Revenue
In the year 2025, Pila Pharma AB had annual revenue of 1.13M SEK with 42.65% growth. Pila Pharma AB had revenue of 275.74K in the half year ending December 31, 2025, a decrease of -24.67%.
Revenue
1.13M
Revenue Growth
+42.65%
P/S Ratio
51.29
Revenue / Employee
1.13M
Employees
1
Market Cap
57.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13M | 336.85K | 42.65% |
| Dec 31, 2024 | 789.89K | -673.13K | -46.01% |
| Dec 31, 2023 | 1.46M | -417.72K | -22.21% |
| Dec 31, 2022 | 1.88M | 1.16M | 161.49% |
| Dec 31, 2021 | 719.23K | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 346.44K | 320.76K | 1,249.10% |
| Dec 31, 2018 | 25.68K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 273.25M |
| Fluicell AB | 20.15M |
| ExpreS2ion Biotech Holding AB | 16.12M |
| AcouSort AB | 10.05M |
| Spago Nanomedical AB | 4.38M |
| 2cureX AB | 1.98M |
| OncoZenge AB | 71.00K |
Pila Pharma AB News
- 5 months ago - Pila Pharma AB Quarterly report: H2 2025 - Filings
- 5 months ago - Pila Pharma AB Annual report: H2 2025 - Filings
- 11 months ago - Pila Pharma AB Quarterly report: H1 2025 - Filings